Tower Research Capital LLC (Trc) Red Hill Biopharma Ltd. Transaction History

Tower Research Capital LLC (Trc)

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$0.5 - $523.8 $3,945 - $4.13 Million	7,890 Added 189.48%	12,054 $6,000
Q2 2022 Aug 15, 2022	SELL	$0.63 - $2.58 $1,561 - $6,393	-2,478 Reduced 37.31%	4,164 $4,000
Q1 2022 May 12, 2022	SELL	$1.65 - $3.12 $3,958 - $7,484	-2,399 Reduced 26.53%	6,642 $17,000
Q4 2021 Feb 14, 2022	SELL	$2.31 - $5.85 $41,210 - $104,364	-17,840 Reduced 66.37%	9,041 $24,000
Q3 2021 Nov 15, 2021	BUY	$4.55 - $10.36 $107,234 - $244,164	23,568 Added 711.38%	26,881 $123,000
Q2 2021 Aug 16, 2021	BUY	$5.98 - $7.51 $9,484 - $11,910	1,586 Added 91.84%	3,313 $23,000
Q1 2021 May 17, 2021	BUY	$6.98 - $11.29 $9,185 - $14,857	1,316 Added 320.19%	1,727 $13,000
Q4 2020 Feb 16, 2021	BUY	$7.81 - $10.39 $3,209 - $4,270	411 New	411 $3,000
Q1 2020 May 15, 2020	SELL	$3.51 - $6.17 $164 - $289	-47 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$5.76 - $7.35 $6,600 - $8,423	-1,146 Reduced 96.06%	47 $0
Q3 2019 Nov 05, 2019	BUY	$6.46 - $8.37 $2,357 - $3,055	365 Added 44.08%	1,193 $8,000
Q2 2019 Aug 13, 2019	SELL	$6.34 - $8.8 $3,854 - $5,350	-608 Reduced 42.34%	828 $5,000
Q1 2019 May 14, 2019	BUY	$6.06 - $9.0 $8,702 - $12,924	1,436 New	1,436 $12,000
Q4 2017 Feb 09, 2018	SELL	$4.58 - $10.81 $0 - $0	0 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$8.25 - $10.81 $0 - $0	0	0 $0

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $557M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.